Manufacturer: Tripada Healthcare
Pharmaceutical name: Propranolol Hydrochloride
Pack: 10 pills (40 mg)
Beloc contains Propranolol, which is a beta-blocker that influences the heart and blood circulation. This medication is utilized to manage tremors, hypertension, angina (chest pain), heart rhythm issues, and other circulatory problems. Beloc may also be prescribed to prevent and manage heart attacks, as well as to decrease the frequency and severity of migraines.
Propranolol works by competing with neurotransmitters to attach to beta1 and beta2 receptors in the heart and blood vessels, leading to a reduction in heart rate, blood pressure, and the workload on the heart following a heart attack.
Beloc is not recommended for patients with certain medical conditions, including: bronchial asthma; COPD; untreated pheochromocytoma; sinus bradycardia; cardiogenic shock; second and third-degree heart block; overt congestive heart failure; sick sinus syndrome; Raynaud’s syndrome; Prinzmetal’s angina; severe peripheral arterial disease; and metabolic acidosis.
The use of Beloc alongside Thioridazine is also prohibited.
Before starting Beloc, patients should disclose their entire medical history and any current medical conditions, such as muscle or nerve disorders, respiratory issues, diabetes, low blood pressure, heart failure, arrhythmias, mental or mood disorders, kidney disease, liver disease, thyroid disorders, pheochromocytoma, and blood circulation issues, to their healthcare provider.
It is advisable to refrain from driving or engaging in activities that require alertness, as this medication may lead to dizziness. Patients should rise slowly from a seated or supine position to avoid lightheadedness and the risk of falling.
This medication falls under Pregnancy Category C. Animal research has indicated potential risks to the fetus, but studies on pregnant humans are insufficient. It should only be used by pregnant women when absolutely necessary and when the benefits significantly outweigh the risks. Propranolol is excreted in breast milk and may be detrimental to a nursing infant. It is essential to consult a physician before breastfeeding while taking this medication.
This medication can affect laboratory tests and yield false positive results, such as in glaucoma screenings and cardiovascular stress tests that utilize arbutamine. Patients should inform their healthcare provider or laboratory personnel that they are currently taking this medication.